FDA Approved: CREON — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approves a supplemental application for CREON (pancrelipase) submitted by AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatectomy
• Pancreatic Duct Obstruction
• Pancreatitis Chronic

Drugs mentioned

• Creon (pancrelipase)

Snippet

SUPPL AP for CREON (PANCRELIPASE)